MedPath

Open Versus Robotic Retromuscular Ventral Hernia Repair

Not Applicable
Completed
Conditions
Ventral Hernia
Interventions
Procedure: robotic ventral hernia repair
Procedure: open ventral hernia repair
Registration Number
NCT03007758
Lead Sponsor
Prisma Health-Upstate
Brief Summary

The purpose of this study is to determine how the robotic retromuscular hernia repair compares to the open retromuscular hernia repair for large hernia defects in patients at higher risk of wound complications.

Detailed Description

All patients presenting to the Greenville Health System Hernia Center who meet the inclusion criteria will be considered for enrollment. Patients who qualify and agree to participate will be randomized 1:1 to robotic retromuscular ventral hernia repair or open retromuscular ventral hernia repair. Data to be collected includes the following: demographic information, medical characteristics, medications, medical and surgical history, operative details, hospital stay data, and patient-reported outcomes via a quality of life questionnaire. Post-operative follow-up will occur at 2 weeks, 6 weeks, 6 months, 1 year and 2 years.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
102
Inclusion Criteria
  • Ventral or incisional hernia measuring ≥ 7 cm and ≤ 15 cm.
  • At least one of the following risk factors: Body Mass Index > 30, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus, current smoker (within 1 month)
Exclusion Criteria
  • Current abdominal wall infection
  • Presence of ileostomy, colostomy, or ileal conduit
  • Center for Disease Control wound class 3 or 4
  • Hernia defect < 7 cm or >15 cm
  • Pregnant women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
robotic ventral hernia repair (VHR)robotic ventral hernia repairRobotic VHR
open ventral hernia repair (VHR)open ventral hernia repairOpen VHR
Primary Outcome Measures
NameTimeMethod
Composite outcome of diagnosis of surgical site occurrence or infection, hospital readmission, or hernia recurrenceThrough study completion, an average of 2 years

A composite outcome of events which are clinically significant including but not limited to seroma requiring procedural intervention, skin dehiscence, cellulitis, hematoma, skin necrosis, and surgical site infections which may require interventions such as wound care or antibiotic therapy.

Secondary Outcome Measures
NameTimeMethod
All surgical site infectionsPost-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years
Length of stay at hospital measured in daysTime from procedure until discharge, an expected range of 2 to10 days
Quality of Life via questionnaireBaseline and Post-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years
Surgical site occurrences requiring procedural interventionPost-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years
All surgical site occurrencesPost-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years
Surgical site infections requiring procedural interventionPost-operatively: 2 weeks, 6 weeks, 6 months, 1 year, 2 years
Operative time (procedure start to procedure finish measured in minutes)Day of surgery
Cost for hospital charges from billing officeThrough study completion, an average of 2 years
© Copyright 2025. All Rights Reserved by MedPath